All start-ups interested in participating in this year’s 10th MEDICA start-up COMPETITION by submitting innovations can send in their application free of charge until September 22, 2021. For more information about the competition: https://www.medica-tradefair.com/mac2.

Healthcare Innovation World Cup for solutions regarding the “Internet of Medical Things”

Start-ups, scale-ups and SMEs also have the option of submitting their Internet of Medical Things (IoMT) solutions free of charge to the 13th Healthcare Innovation World Cup. The best 12 selected finalists are invited to present their products at MEDICA 2021 (on November 15/ also in hall 12 + online), which can range from wearable technologies to digital biomarkers, intelligent plasters and smart implants. inContAlert was one of the winners in 2020. Its system of the same name measures bladder fullness non-invasively. This can be important for patients who can no longer feel their bladder, for example in the case of paraplegia or multiple sclerosis. With this information, they can, on the one hand, avoid uncontrolled bladder secretions and, on the other hand, prevent bladder cramping and its harmful consequences for the kidneys. Today, inContAlert has four full-time and eight part-time employees. While MEDICA 2020 was taking place, the company and its team were financed by the Medical Valley Award. Shortly after MEDICA, the new round of funding began under very good circumstances.

“We use accelerator programs and competitions,” says Dr Jannik Lockl, co-founder of inContAlert. The company founders actually met for the first time at one such event when they participated in the International Business Plan Competition in Hong Kong. There, top physicians described challenges waiting for a solution, which inspired the co-founders to come up with the idea for inContAlert.

Good organization and a great deal of attention

Now, Dr. Lockl can compare his experiences from multiple competitions: “I was surprised by the excellent organization of and the positive media reaction to the Healthcare Innovation World Cup. It raised awareness of our company with potential partners. We profited a great deal from our presentation at MEDICA.” Today, inContAlert is well on the way to access the market. However, as a Class 1m medical device, economic effects must first be proven. These could be, for example, reducing diaper use or improving patients’ quality of life. In addition, the decreased use of catheters is likely to reduce the probability of urinary tract infections or kidney damage. However, it will be a matter of years before this medical benefit can be scientifically proven. For now, the company is focusing on launching its product on the market.

Business Affairs Homepage